Results of the present study showed that JPYST inhibits the NF-κB activation in TECs, indicating JPYST experts antiapoptotic and anti-inflammatory effects by suppressing the NF-κB signaling pathway in CDDP-induced AKI. The gene discussed is NFKB1; the disease is acute kidney injury.